Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2232 participants.

Also called NCT02757872

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 2,232 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02757872
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02757872. Randomized; triple masking; primary purpose prevention. Start 2016-04 (actual); primary completion 2022-03-31 (actual). Results posted on 2024-05-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Condition
Hypertension
Condition
Kidney Diseases
Intervention (Dietary supplement)
Vitamin D3
Intervention (Drug)
Omega-3 Fatty acids
Intervention (Dietary supplement)
Vitamin D3 placebo
Intervention (Dietary supplement)
Fish oil placebo
Lead sponsor
Albert Einstein College of Medicine (class: other)
Collaborator
Brigham and Women's Hospital (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02757872
Content hash
402f9fc39d41691af1a67fe3537bc5bc8830bf0a38a632aab9f4dd54417370fa